Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation

• Published in: Vaccines (Basel) Vol. 8; no. 2; p. 272
• Main Authors: Rizzo, Chiara, Grasso, Giulia, Destro Castaniti, Giulia Maria, Ciccia, Francesco, Guggino, Giuliana
• Format: Journal Article
• Language: English
• Published: MDPI 03.06.2020; MDPI AG
• Subjects: cytokines; IFN signature; inflammation; innate immunity; innate lymphoid cells; Review; Sjogren syndrome
• ISSN: 2076-393X; 2076-393X
• DOI: 10.3390/vaccines8020272

Primary Sjogren Syndrome (pSS) is a complex, multifactorial rheumatic disease that mainly targets salivary and lacrimal glands, inducing epithelitis. The cause behind the autoimmunity outbreak in pSS is still elusive; however, it seems related to an aberrant reaction to exogenous triggers such as viruses, combined with individual genetic pre-disposition. For a long time, autoantibodies were considered as the hallmarks of this disease; however, more recently the complex interplay between innate and adaptive immunity as well as the consequent inflammatory process have emerged as the main mechanisms of pSS pathogenesis. The present review will focus on innate cells and on the principal mechanisms of inflammation connected. In the first part, an overview of innate cells involved in pSS pathogenesis is provided, stressing in particular the role of Innate Lymphoid Cells (ILCs). Subsequently we have highlighted the main inflammatory pathways, including intra- and extra-cellular players. A better knowledge of such processes could determine the detection of new therapeutic targets that are a major need for pSS.